Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases Vedolizumab (VDZ) is a humanized immunoglobulin G1 monoclonal antibody acting against α4β7 integrin which modulates lymphocyte trafficking in the gut. Results from the adult GEMINI-1 and ...

• Country None
• organs None
• Specialty None

Manipulating the Microbiome in IBD by Antibiotics and FMT the etiology of Inflammatory Bowel Diseases (IBD) is closely associated with the gut microbiome. The results of previous studies on the effectiveness of antibiotics and fecal macrobiota tr...

• Country None
• organs None
• Specialty None